2 results
Approved WMOCompleted
To confirm the safety of the Articulinx implant by evaluating device and procedure related adverse events.
Approved WMOCompleted
The primary objective of this study is:• To evaluate whether simtuzumab (formally referred to as GS-6624) is effective at preventing the progression of liver fibrosis in subjects with PSC.The secondary objectives of this study include the following…